General surgeons are frequently confronted with colorectal diseases in their daily practice, whereby colorectal cancer is the second most common malignant tumour, with almost 5000 new cases every year in Austria. The incidence of benign colon disorders requiring surgery (e.g. colon polyps, sigmoid diverticulitis) is also increasing.
The first aim in colon surgery should be to avoid complications and if they occur to treat them properly.We basically distinguish between general and special complications.
As general complications, prevention of malnutrition and support of the immune system should receive special attention. As the number of elderly patients increases, so does the risk not only of thrombembolic complications but also of critical cardiocirculatory situations, and renal and hepatic failure.
SKT (KIAA1217) Antibody |
|
abx234542-100g |
Abbexa |
100 µg |
EUR 350 |
SKT (KIAA1217) Antibody |
|
abx234542-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
|
Mouse SKT shRNA Plasmid |
|
20-abx980555 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Mouse Sickle tail protein (SKT) ELISA Kit |
|
abx389166-96tests |
Abbexa |
96 tests |
EUR 687.5 |
|
|
SKT (KIAA1217) (NM_019590) Human Over-expression Lysate |
|
E45H11013-2 |
EnoGene |
each |
EUR 395 |
SKT (KIAA1217) (NM_019590) Human Over-expression Lysate |
|
LS056243 |
BosterBio |
100ug |
EUR 960 |
|
|
|
Description: Transient overexpression lysate of KIAA1217 (KIAA1217), transcript variant 1 |
Recombinant Mouse Sickle tail protein (Skt) , partial |
|
MBS1201914-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Human Sickle tail protein homolog, SKT ELISA KIT |
|
ELI-18163h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Recombinant Human Sickle tail protein homolog (SKT) , partial |
|
MBS1296028-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Skt ELISA Kit| Mouse Sickle tail protein ELISA Kit |
|
EF014796 |
Lifescience Market |
96 Tests |
EUR 826.8 |
MNI 137 |
|
B5571-10 |
ApexBio |
10 mg |
EUR 428 |
|
|
|
Description: Neuroscience|GluR |
MNI 137 |
|
B5571-50 |
ApexBio |
50 mg |
EUR 1394.4 |
|
|
|
Description: Neuroscience|GluR |
BCI-137 |
|
HY-119024 |
MedChemExpress |
10 mg |
EUR 1033.57 |
|
Description: BCI-137 is a competitive AGO2 inhibitor, with an IC50 of 342 μM. BCI-137 tightly binds to several residues of the Mid domain[1]. |
Anticancer agent 137 |
|
HY-155570 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 137 (8q) is a potent PI3k inhibitor. Anticancer agent 137 has broad-spectrum anticancer activity. Anticancer agent 137 induces G2/M cell cycle arrest and apoptosis. Anticancer agent 137 increases cleaved PARP, caspase 3, and 7. Anticancer agent 137 can be used in research of cancer[1]. |
ZXH-4-137 |
|
HY-132862 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: ZXH-4-137 is a potent and selective CRBN degrader (PROTAC). |
CD147 (BSB-137) |
|
MBS370470-01mLConcentrate |
MyBiosource |
0.1mL(Concentrate) |
EUR 280 |
CD147 (BSB-137) |
|
MBS370470-05mLConcentrate |
MyBiosource |
0.5mL(Concentrate) |
EUR 540 |
CD147 (BSB-137) |
|
MBS370470-15mLRTU |
MyBiosource |
15mL(RTU) |
EUR 830 |
CD147 (BSB-137) |
|
MBS370470-3mLRTU |
MyBiosource |
3mL(RTU) |
EUR 305 |
CD147 (BSB-137) |
|
MBS370470-7mLRTU |
MyBiosource |
7mL(RTU) |
EUR 500 |
Recombinant HAdV-2 B-137 Protein (aa 1-137) |
|
VAng-Cr4236-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 3688.8 |
|
Description: HAdV-2 Uncharacterized protein B-137, recombinant protein. |
Recombinant HAdV-2 B-137 Protein (aa 1-137) |
|
VAng-Cr4236-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2650.8 |
|
Description: HAdV-2 Uncharacterized protein B-137, recombinant protein. |
Recombinant HAdV-2 B-137 Protein (aa 1-137) |
|
VAng-Cr4236-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1825.2 |
|
Description: HAdV-2 Uncharacterized protein B-137, recombinant protein. |
RNF8 (Ab-137) Antibody |
|
21699-100ul |
SAB |
100ul |
EUR 302.4 |
RNF8 (Ab-137) Antibody |
|
21699-50ul |
SAB |
50ul |
EUR 224.4 |
HIST1H1B (Ab-137) Antibody |
|
1-CSB-PA010377PA137nphHU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against HIST1H1B (Ab-137). Recognizes HIST1H1B (Ab-137) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:200-1:2000, IHC:1:20-1:200 |
RNF8 (Ab-137) Antibody |
|
E021699 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
Profilin (a.a. 126-137) |
|
MBS474133-01mL |
MyBiosource |
0.1mL |
EUR 370 |
Profilin (a.a. 126-137) |
|
MBS474133-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1505 |
HIST1H1B (Ab-137) Antibody |
|
MBS7106722-005mL |
MyBiosource |
0.05mL |
EUR 195 |
HIST1H1B (Ab-137) Antibody |
|
MBS7106722-01mL |
MyBiosource |
0.1mL |
EUR 285 |
HIST1H1B (Ab-137) Antibody |
|
MBS7106722-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1275 |
rno-miR-137 Primers |
|
MP-r00102 |
ABM |
150 ul / 10 uM |
EUR 211.2 |
hsa-miR-137 Primers |
|
MPH01155 |
ABM |
150 ul / 10 uM |
EUR 145.2 |
mmu-miR-137 Primers |
|
MPM00077 |
ABM |
150 ul / 10 uM |
EUR 145.2 |
RNF8 (Ab-137) Antibody |
|
MBS9411285-005mL |
MyBiosource |
0.05mL |
EUR 245 |
RNF8 (Ab-137) Antibody |
|
MBS9411285-01mL |
MyBiosource |
0.1mL |
EUR 305 |
RNF8 (Ab-137) Antibody |
|
MBS9411285-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1230 |
miRVec-hsa-miR-137 |
|
PPL00414-3a |
Bioworld Biotech |
412bp |
EUR 218 |
|
|
|
Description: miRVec |
p60 v-src (137-157) |
|
5-01682 |
CHI Scientific |
4 x 1mg |
EUR 158.34 |
|
Description: Val-Ala-Pro-Ser-Asp-Ser-Ile-Gln-Ala-Glu-Glu-Trp-Tyr-Phe-Gly-Lys-Ile-Thr-Arg-Arg-Glu |
RNF8 (Ab-137) Conjugated Antibody |
|
C21699 |
SAB |
100ul |
EUR 476.4 |
p60 v-src (137-157) |
|
H-8535.0500 |
Bachem |
0.5mg |
EUR 254.4 |
|
Description: Sum Formula: C111H168N30O35; CAS# [131023-24-0] |
p60 v-src (137-157) |
|
H-8535.1000 |
Bachem |
1.0mg |
EUR 400.8 |
|
Description: Sum Formula: C111H168N30O35; CAS# [131023-24-0] |
MDM4 (1-137) recombinant protein |
|
MBS515348-002mg |
MyBiosource |
0.02mg |
EUR 305 |
MDM4 (1-137) recombinant protein |
|
MBS515348-005mg |
MyBiosource |
0.05mg |
EUR 495 |
MDM4 (1-137) recombinant protein |
|
MBS515348-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1965 |
hsa-miR-137 miRNA Inhibitor |
|
MBS8292902-10nmol |
MyBiosource |
10nmol |
EUR 210 |
hsa-miR-137 miRNA Inhibitor |
|
MBS8292902-20nmol |
MyBiosource |
20nmol |
EUR 265 |
hsa-miR-137 miRNA Inhibitor |
|
MBS8292902-5x20nmol |
MyBiosource |
5x20nmol |
EUR 1110 |
p60 v-src (137-157) |
|
MBS8246862-10mg |
MyBiosource |
10mg |
EUR 915 |
p60 v-src (137-157) |
|
MBS8246862-1mg |
MyBiosource |
1mg |
EUR 315 |
p60 v-src (137-157) |
|
MBS8246862-5mg |
MyBiosource |
5mg |
EUR 645 |
p60 v-src (137-157) |
|
MBS8246862-5x10mg |
MyBiosource |
5x10mg |
EUR 4035 |
rno??miR-137 miRNA Antagomir |
|
MNR01112 |
ABM |
2 x 5.0 nmol |
EUR 394.8 |
hsa-miR-137 miRNA Inhibitor |
|
MIH01297 |
ABM |
2 x 5.0 nmol |
EUR 211.2 |
rno??miR-137 miRNA Inhibitor |
|
MIR01112 |
ABM |
2 x 5.0 nmol |
EUR 211.2 |
hsa-miR-137 miRNA Antagomir |
|
MNH01297 |
ABM |
2 x 5.0 nmol |
EUR 394.8 |
mmu-miR-137 miRNA Inhibitor |
|
MIM01172 |
ABM |
2 x 5.0 nmol |
EUR 211.2 |
rno-miR-137-3p Primers |
|
MPR00382 |
ABM |
150 ul / 10 uM |
EUR 211.2 |
rno-miR-137-5p Primers |
|
MPR00383 |
ABM |
150 ul / 10 uM |
EUR 211.2 |
mmu-miR-137 miRNA Antagomir |
|
MNM01172 |
ABM |
2 x 5.0 nmol |
EUR 394.8 |
mmu-miR-137-3p Primers |
|
MPM00836 |
ABM |
150 ul / 10 uM |
EUR 145.2 |
mmu-miR-137-5p Primers |
|
MPM00837 |
ABM |
150 ul / 10 uM |
EUR 145.2 |
RNF8 (Ab-137) Conjugated Antibody |
|
MBS9438977-01mLAF350 |
MyBiosource |
0.1mL(AF350) |
EUR 480 |
RNF8 (Ab-137) Conjugated Antibody |
|
MBS9438977-01mLAF405 |
MyBiosource |
0.1mL(AF405) |
EUR 480 |
RNF8 (Ab-137) Conjugated Antibody |
|
MBS9438977-01mLAF488 |
MyBiosource |
0.1mL(AF488) |
EUR 480 |
RNF8 (Ab-137) Conjugated Antibody |
|
MBS9438977-01mLAF555 |
MyBiosource |
0.1mL(AF555) |
EUR 480 |
RNF8 (Ab-137) Conjugated Antibody |
|
MBS9438977-01mLBiotin |
MyBiosource |
0.1mL(Biotin) |
EUR 480 |
Recombinant BRDT (21-137) protein |
|
MBS388164-01mg |
MyBiosource |
0.1mg |
EUR 585 |
Recombinant BRDT (21-137) protein |
|
MBS388164-1mg |
MyBiosource |
1mg |
EUR 3345 |
Recombinant BRDT (21-137) protein |
|
MBS388164-5x1mg |
MyBiosource |
5x1mg |
EUR 14870 |
hsa-miR-137 miRNA Mimic |
|
MBS8298149-10nmol |
MyBiosource |
10nmol |
EUR 265 |
hsa-miR-137 miRNA Mimic |
|
MBS8298149-5nmol |
MyBiosource |
5nmol |
EUR 210 |
hsa-miR-137 miRNA Mimic |
|
MBS8298149-5x10nmol |
MyBiosource |
5x10nmol |
EUR 1110 |
MV1LU CELLS 96 WELL/ 96 FILL |
|
58-9696B |
Quidel |
each |
Ask for price |
|
Description: flask ; Single or Mixed |
CometAssay 96 |
|
4253-096-K |
Biotechne |
96 tests |
EUR 513.6 |
Butyroin 96% |
|
B31520 |
Pfaltz & Bauer |
10G |
EUR 176.06 |
|
|
|
Description: CAS N° 496-77-5 |
Benzazimide 96% |
|
B01380 |
Pfaltz & Bauer |
5G |
EUR 78.74 |
|
Description: CAS N° 90-16-4 |
Diethylsilane 96% |
|
D24635 |
Pfaltz & Bauer |
5G |
EUR 290.77 |
|
Description: CAS N° 542-91-6 |
Decaborane 96% |
|
D00150 |
Pfaltz & Bauer |
1G |
EUR 264.98 |
|
|
|
Description: CAS N° 17702-41-9 |
Indoline 96% |
|
I01740 |
Pfaltz & Bauer |
100G |
EUR 119.52 |
|
Description: CAS N° 496-15-1 |
Targaprimir-96 |
|
HY-135276 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Targaprimir-96 is a potent inhibitor of microRNA-96 (miR-96) processing. Targaprimir-96 selectively modulates miR-96 production in cancer cells and triggers apoptosis. Targaprimir-96 binds primary miR-96 (pri-miR-96) with low nanomolar affinity. Targaprimir-96 directly engages pri-miR-96 in breast cancer cells and is ineffective on healthy breast cells[1]. |
SP-96 |
|
HY-131339 |
MedChemExpress |
10 mg |
EUR 1071.45 |
|
Description: SP-96 is a highly potent, selective and non-ATP-competitive Aurora B (IC50=0.316 nM) inhibitor and shows >2000 fold selectivity against FLT3 and KIT. SP-96 shows selective growth inhibition in NCI60 screening, incluing MDA-MD-468 (GI50=107 nM). SP-96 can be used for the research of triple negative breast cancer (TNBC)[1]. |
Hexachlorodisiloxane 96% |
|
H02650 |
Pfaltz & Bauer |
10G |
EUR 554 |
|
Description: CAS N° 14986-21-1 |
Hexachloropropene 96% |
|
H02770 |
Pfaltz & Bauer |
5G |
EUR 143.51 |
|
|
|
Description: CAS N° 1888-71-7 |
Methyldiethoxysilane 96% |
|
M15885 |
Pfaltz & Bauer |
1G |
EUR 103.08 |
|
|
|
Description: CAS N° 2031-62-1 |
Targaprimir-96 |
|
MBS5767702-5x5mg |
MyBiosource |
5x5mg |
EUR 3970 |
Phenyldichlorosilane 96% |
|
P10770 |
Pfaltz & Bauer |
5G |
EUR 138.28 |
|
Description: CAS N° 1631-84-1 |
Pinacolone 96% |
|
P19520 |
Pfaltz & Bauer |
25G |
EUR 109.1 |
|
|
|
Description: CAS N° 75-97-8 |
Triphenylsilane 96% |
|
T30895 |
Pfaltz & Bauer |
5G |
EUR 119.26 |
|
Description: CAS N° 789-25-3 |
Tetraphenylsilane 96% |
|
T08670 |
Pfaltz & Bauer |
5G |
EUR 227.63 |
|
Description: CAS N° 1048-08-4 |
Trimethylacetaldehyde 96% |
|
T26315 |
Pfaltz & Bauer |
5G |
EUR 257.01 |
|
|
|
Description: CAS N° 630-19-3 |
Tetrabromocatechol 96% |
|
T01850 |
Pfaltz & Bauer |
5G |
EUR 135.54 |
|
|
|
Description: CAS N° 488-47-1 |
prepro-NGF, beta (109-137) (Human) |
|
016-13 |
PHOENIX PEPTIDE |
100 μg |
EUR 316.44 |
THT-137-499-3 AB Labels |
|
062370 |
BRADY NV |
Roll of 3000 Label(s) |
EUR 300.52 |
|
Description: Description Dutch: Thermische transfert labels; Description French: Etiquettes imprimables par transfert thermique |
DAT-137-502-10 AB Labels |
|
027337 |
BRADY NV |
Pack of 10000 Label(s) |
EUR 371.03 |
|
Description: Description Dutch: DaTab Dot Matrix Beprintbare Labels; Description French: Etiquettes Dot Matrix DaTab |
THT-137-7425-2 AB Labels |
|
121011 |
BRADY NV |
Roll of 2000 Label(s) |
EUR 127.46 |
|
Description: Description Dutch: Met thermische transfertprinter bedrukbare labels; Description French: Étiquettes imprimables par transfert thermique |
STN 137-450X150-B7527 AC Signs |
|
252351 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 15.95 |
|
Description: Description Dutch: Verbodspictogram - Gebruik van GSM verboden; Description French: Pictogramme - Interdiction - Gebruik van GSM verboden |
B33-137-7425 AF Systems Consumables |
|
148683 |
BRADY NV |
Roll of 1500 Label(s) |
EUR 241.48 |
|
Description: Description Dutch: Polypropyleenlabels voor de BBP33/i3300 printer; Description French: Étiquettes en polypropylène pour l’imprimante BBP33/i3300 |
B33-137-427AW AF Systems Consumables |
|
143045 |
BRADY NV |
Box of 1500 Label(s) |
EUR 183.13 |
|
Description: Description Dutch: Vinyllabels voor BBP33/i3300-printers; Description French: Étiquettes en vinyle pour imprimantes BBP33/i3300 |
B33-137-499 AF Systems Consumables |
|
143066 |
BRADY NV |
Box of 1100 Label(s) |
EUR 132.7 |
|
Description: Description Dutch: Labels uit nylonweefsel voor BBP33/i3300-printers; Description French: Étiquettes en tissu nylon pour imprimantes BBP33/i3300 |
Human hsa-miR-137 miRNA Agomir |
|
abx880102-10nmol |
Abbexa |
10 nmol |
EUR 575 |
Human hsa-miR-137 miRNA Agomir |
|
abx880102-5nmol |
Abbexa |
5 nmol |
EUR 425 |
p60 v-src (137-157) Peptide |
|
abx266840-1ml |
Abbexa |
1 ml |
EUR 475 |
p60 v-src (137-157) Peptide |
|
abx266840-200l |
Abbexa |
200 µl |
EUR 225 |
hsa-miR-137 miRNA Agomir/Antagomir |
|
AM2451 |
AcceGen |
2 OD, 4 OD, 50 OD (size by request, 1 OD corresponds to 33 ug) |
Ask for price |
|
Description: MicroRNA: hsa-miR-137Accession Number: MIMAT0000429Mature Sequence: UUAUUGCUUAAGAAUACGCGUAGhsa-miR-137 are small non-coding RNAs of 20-22 nucleotides, typically excised from 60-110 nucleotide foldback RNA precursor structures. miRNAs are involved in crucial biological processes, including development, differentiation, apoptosis, and proliferation, through imperfect pairing with target messenger RNAs (mRNAs) of protein-coding genes and the transcriptional or post-transcriptional regulation of their expression. Click here to browse detailed information about hsa-miR-137 in miRBase.What is MicroRNA Agomir/Antagomir?MicroRNA Agomir is a special-labeled and chemically modified double-stranded small RNA that mimics the endogenous miRNA to regulate the biological function of the target gene. MicroRNA Antagomir is an especially chemically modified miRNA antagonist. It strongly competes with mature miRNAs in the body to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.Why choose hsa-miR-137 miRNA Agomir/Antagomir from Gentaur has extended experience in MicroRNA Agomir/Antagomir synthesis services that cover all human, mouse, and rat miRNAs in the current miRBase. Compared to standard miRNA mimics and inhibitors, Gentaur miRNA agomir and antagomir are more resistant to degradation, thus having a lasting effect: minimum for 1 week, up to 5-6 weeks. These products can be used in in vitro or in vivo miRNA functional studies. |
Human hsa-miR-137 miRNA Antagomir |
|
abx885349-10nmol |
Abbexa |
10 nmol |
EUR 425 |
Human hsa-miR-137 miRNA Antagomir |
|
abx885349-20nmol |
Abbexa |
20 nmol |
EUR 575 |
NPDC-1 (137-176) (Human) - Antibody |
|
H-002-62 |
PHOENIX PEPTIDE |
100 μl |
EUR 604.8 |
mmu-miR-137-5p miRNA Inhibitor |
|
MBS8296224-10nmol |
MyBiosource |
10nmol |
EUR 210 |
mmu-miR-137-5p miRNA Inhibitor |
|
MBS8296224-20nmol |
MyBiosource |
20nmol |
EUR 265 |
mmu-miR-137-5p miRNA Inhibitor |
|
MBS8296224-5x20nmol |
MyBiosource |
5x20nmol |
EUR 1110 |
mmu-miR-137-3p miRNA Inhibitor |
|
MBS8295416-10nmol |
MyBiosource |
10nmol |
EUR 210 |
mmu-miR-137-3p miRNA Inhibitor |
|
MBS8295416-20nmol |
MyBiosource |
20nmol |
EUR 265 |
mmu-miR-137-3p miRNA Inhibitor |
|
MBS8295416-5x20nmol |
MyBiosource |
5x20nmol |
EUR 1110 |
mmu-miR-137-5p miRNA Mimic |
|
MBS8301471-10nmol |
MyBiosource |
10nmol |
EUR 265 |
mmu-miR-137-5p miRNA Mimic |
|
MBS8301471-5nmol |
MyBiosource |
5nmol |
EUR 210 |
mmu-miR-137-5p miRNA Mimic |
|
MBS8301471-5x10nmol |
MyBiosource |
5x10nmol |
EUR 1110 |
rno-miR-137-3p miRNA Antagomir |
|
MNR01113 |
ABM |
2 x 5.0 nmol |
EUR 394.8 |
rno-miR-137-5p miRNA Antagomir |
|
MNR01114 |
ABM |
2 x 5.0 nmol |
EUR 394.8 |
rno-miR-137-3p miRNA Inhibitor |
|
MIR01113 |
ABM |
2 x 5.0 nmol |
EUR 211.2 |
rno-miR-137-5p miRNA Inhibitor |
|
MIR01114 |
ABM |
2 x 5.0 nmol |
EUR 211.2 |
mmu-miR-137-3p miRNA Inhibitor |
|
MIM01173 |
ABM |
2 x 5.0 nmol |
EUR 211.2 |
mmu-miR-137-5p miRNA Inhibitor |
|
MIM01174 |
ABM |
2 x 5.0 nmol |
EUR 211.2 |
mmu-miR-137-3p miRNA Antagomir |
|
MNM01173 |
ABM |
2 x 5.0 nmol |
EUR 394.8 |
mmu-miR-137-5p miRNA Antagomir |
|
MNM01174 |
ABM |
2 x 5.0 nmol |
EUR 394.8 |
mmu-miR-137-3p miRNA Mimic |
|
MBS8300663-10nmol |
MyBiosource |
10nmol |
EUR 265 |
mmu-miR-137-3p miRNA Mimic |
|
MBS8300663-5nmol |
MyBiosource |
5nmol |
EUR 210 |
mmu-miR-137-3p miRNA Mimic |
|
MBS8300663-5x10nmol |
MyBiosource |
5x10nmol |
EUR 1110 |
rno-miR-137-3p miRNA Inhibitor |
|
MBS8297403-10nmol |
MyBiosource |
10nmol |
EUR 210 |
rno-miR-137-3p miRNA Inhibitor |
|
MBS8297403-20nmol |
MyBiosource |
20nmol |
EUR 265 |
rno-miR-137-3p miRNA Inhibitor |
|
MBS8297403-5x20nmol |
MyBiosource |
5x20nmol |
EUR 1110 |
rno-miR-137-5p miRNA Mimic |
|
MBS8302970-10nmol |
MyBiosource |
10nmol |
EUR 265 |
rno-miR-137-5p miRNA Mimic |
|
MBS8302970-5nmol |
MyBiosource |
5nmol |
EUR 210 |
rno-miR-137-5p miRNA Mimic |
|
MBS8302970-5x10nmol |
MyBiosource |
5x10nmol |
EUR 1110 |
rno-miR-137-5p miRNA Inhibitor |
|
MBS8297723-10nmol |
MyBiosource |
10nmol |
EUR 210 |
Special complications depend either on the type of surgery (laparoscopic assisted, conventional open surgery) or the techniques employed (stapled, hand sutured). Handling of the tissue also plays a major role (e.g. dry versus wet pads).